Culture conversion and six months interim outcomes in retreatment cases of pulmonary MDRTB - a six month interim analysis.

Abstract

OBJECTIVE:

To estimate the time to culture conversion and factors associated with failure to culture conversion, six-month interim outcomes and associated risk factors with poor interim outcomes in multi-drug resistant tuberculosis patients previously treated with second-line drugs.

METHODS:

The prospective clinical case series study was conducted from March 2016 to January 2017 at the Indus Hospital Tuberculosis Clinic and seven other sites that are part of the hospital's Programmatic Management of Drug Resistant Tuberculosis initiative. All bacteriologically confirmed multi-drug resistant tuberculosis retreatment patients were enrolled. Data was collected on age, gender, site of enrollment, detailed history of previous treatment with anti-tuberculosis drugs, medical history, history of first-line drugs, history of second-line drugs, treatment outcomes, baseline sputum smear microscopy and monthly follow-up sputum smear microscopy and culture results. Data was subjected to univariate and multiple logistic regression analyses, and risk factors for failure to culture conversion were assessed using Cox Proportional Hazards Model.

RESULTS:

Out of 266 patients, 143(53.8%) were males, the overall largest age group was 5-24 years 97(36.5%), and 250 (94%) patients had previous history of treatment with first-line drugs. Overall, 101(40.1%) patients experienced poor interim outcome. Poor interim outcomes were significantly associated with higher number of drugs on the regimen, (odds ratio: 1.27; 95% confidence interval: 1.03-1.58) and high sputum smear grading (odds ratio: 4.56; 95% confidence interval: 3.30-18.71). Besides, 186(70.3%) patients experienced culture conversion within the initial six months of treatment.

CONCLUSIONS:

The success rate of re-treatment of multi-drug resistant tuberculosis with conventional regimen was found to be unacceptably low.

• Authors: Rabab Batool, Sher Wali Khan, Mohammad Imran, Zainab Barry, Sheikh Zafar Ali
• Journal: JPMA. The Journal of the Pakistan Medical Association (J Pak Med Assoc) Vol. 71 Issue 12 Pg. 2710-2716 (Dec 2021) ISSN: 0030-9982 [Print] Pakistan
• PMID: 35150525 (Publication Type: Journal Article)

Chemical References

• Antitubercular Agents

Topics

• Adolescent
• Adult
• Antitubercular Agents (therapeutic use)
• Child
• Child, Preschool
• Humans
• Male
• Mycobacterium tuberculosis
• Prospective Studies
• Retreatment
• Retrospective Studies
• Sputum
• Treatment Outcome
• Tuberculosis, Multidrug-Resistant (drug therapy, epidemiology)
• Young Adult